UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                  -------------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                Date of Report (Date of earliest event reported)
                                  March 8, 2006

                                SEARCHHELP, INC.
             (Exact name of registrant as specified in its charter)


           DELAWARE                    333-97687                 11-3621755
--------------------------------------------------------------------------------
(State or other jurisdiction    (Commission File Number)       (IRS Employer
      of incorporation)                                      Identification No.)


                  1055 Stewart Avenue, Suite 12, Bethpage, New
                   York 11714 (Address of principal executive
                          offices, including zip code)

                                  516-922-4765
              (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|   Written communication pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))


<PAGE>

Item 2.06 Material Impairments.

      As a result of the review of our financial statements by our Board of
Directors in connection with the preparation of our Annual Report on Form 10-KSB
for the year ended December 31, 2005, and after reviewing certain accounting
principles we have applied in previously issued financial statements, on March
8, 2006 our Board of Directors determined that the carrying value of a Deferred
License Fee was impaired at December 31, 2005 and should be written off in its
entirety. The Deferred License Fee relates to SearchHelp's participation
interest in certain revenues from a mold-remediation product licensed to
Environmental Commercial Technology Corp. ("ECT"). SearchHelp originally
acquired this participation interest on February 3, 2004, as more fully
discussed in SearchHelp's amended Annual Report on Form 10-KSB for the year
ended December 31, 2004, filed with the Securities and Exchange Commission on
August 24, 2005.

      Previously, the Deferred License Fee had been presented at a value of
$1,950,000 at December 31, 2004 and $1,750,000 at September 30, 2005,
respectively. In making its determination, the Board considered, among others,
the following factors: delays in the development of the mold-remediation product
relating to its chemical formulation; statements by BioNeutral Laboratories
Corporation USA ("BioUSA"), the parent company of ECT, that such product would
not be ready for market until at least late 2007; projections furnished by
BioUSA estimating aggregate revenue for the mold-remediation product of only
$2.5 million for the period 2007-2010; and BioUSA's working capital position and
need for additional financing. Following its review, the Board determined that
the carrying value of the Deferred License Fee should be reduced to zero.

      This impairment will have no impact on SearchHelp's future cash
expenditures. However, pursuant to a Settlement Agreement entered into on
October 20, 2005 between SearchHelp and BioUSA, SearchHelp continues to be
obligated to pay a total of $100,000, in two installments of $50,000 each due on
October 20, 2006 and 2007, respectively. SearchHelp has commenced litigation
against BioUSA seeking to have this payment obligation nullified, although such
litigation is in a preliminary stage and its outcome cannot be predicted at this
time. Accordingly, SearchHelp will continue to carry this obligation on its
financial statements at December 31, 2005, March 31, 2006 and possibly
thereafter.


<PAGE>

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


Dated: March 8, 2006

                                      SEARCHHELP, INC.

                                      By:  /s/ William Bozsnyak
                                           --------------------------------
                                      Name:    William Bozsnyak
                                      Title:   Chief Executive Officer
{"company-data": {"conformed-name": "SEARCHHELP INC", "cik": "0001163573", "assigned-sic": "7380", "irs-number": "113621755", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-31590", "film-number": "06674425"}, "mail-address": {"street1": "1055 STEWART AVE STE 12", "city": "BETHPAGE", "state": "NY", "zip": "11714"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                  -------------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                Date of Report (Date of earliest event reported)
                                  March 8, 2006

                                SEARCHHELP, INC.
             (Exact name of registrant as specified in its charter)

           DELAWARE                    333-97687                 11-3621755
--------------------------------------------------------------------------------
(State or other jurisdiction    (Commission File Number)       (IRS Employer
      of incorporation)                                      Identification No.)

                  1055 Stewart Avenue, Suite 12, Bethpage, New
                   York 11714 (Address of principal executive
                          offices, including zip code)

                                  516-922-4765
              (Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|   Written communication pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))
Item 2.06 Material Impairments.

      As a result of the review of our financial statements by our Board of
Directors in connection with the preparation of our Annual Report on Form 10-KSB
for the year ended December 31, 2005, and after reviewing certain accounting
principles we have applied in previously issued financial statements, on March
8, 2006 our Board of Directors determined that the carrying value of a Deferred
License Fee was impaired at December 31, 2005 and should be written off in its
entirety. The Deferred License Fee relates to SearchHelp's participation
interest in certain revenues from a mold-remediation product licensed to
Environmental Commercial Technology Corp. ("ECT"). SearchHelp originally
acquired this participation interest on February 3, 2004, as more fully
discussed in SearchHelp's amended Annual Report on Form 10-KSB for the year
ended December 31, 2004, filed with the Securities and Exchange Commission on
August 24, 2005.

      Previously, the Deferred License Fee had been presented at a value of
$1,950,000 at December 31, 2004 and $1,750,000 at September 30, 2005,
respectively. In making its determination, the Board considered, among others,
the following factors: delays in the development of the mold-remediation product
relating to its chemical formulation; statements by BioNeutral Laboratories
Corporation USA ("BioUSA"), the parent company of ECT, that such product would
not be ready for market until at least late 2007; projections furnished by
BioUSA estimating aggregate revenue for the mold-remediation product of only
$2.5 million for the period 2007-2010; and BioUSA's working capital position and
need for additional financing. Following its review, the Board determined that
the carrying value of the Deferred License Fee should be reduced to zero.

      This impairment will have no impact on SearchHelp's future cash
expenditures. However, pursuant to a Settlement Agreement entered into on
October 20, 2005 between SearchHelp and BioUSA, SearchHelp continues to be
obligated to pay a total of $100,000, in two installments of $50,000 each due on
October 20, 2006 and 2007, respectively. SearchHelp has commenced litigation
against BioUSA seeking to have this payment obligation nullified, although such
litigation is in a preliminary stage and its outcome cannot be predicted at this
time. Accordingly, SearchHelp will continue to carry this obligation on its
financial statements at December 31, 2005, March 31, 2006 and possibly
thereafter.
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

Dated: March 8, 2006

                                      SEARCHHELP, INC.

                                      By:  /s/ William Bozsnyak
                                           --------------------------------
                                      Name:    William Bozsnyak
                                      Title:   Chief Executive Officer